Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-26 @ 2:03 AM
Study NCT ID:
NCT06121505
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2023-10-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer
Sponsor:
Sichuan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-31
First Submit QC Date:
None
Study First Post Date:
2023-11-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-09
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED